Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Amended on May 16, 2022 – the version known today is shown.

You are looking at Q4 2021. Go to the latest filing (Q3 2026)

34.5B USDQ4 2021
Total value of stock positions
34.5B USD
Positions
105
Share of the ten largest
37.6%

The ten largest positions Q4 2021

  1. Ginkgo Bioworks Holdings Inc 8.2%unchanged
  2. GE Aerospace 4.9%▲ +6.6%
  3. T-Mobile US 4.4%▲ +28.6%
  4. Humana 3.6%▼ −11.4%
  5. Brookfield Asset Mgmt Inc 3.1%▲ +3.6%
  6. Microsoft 2.9%▼ −19.5%
  7. Parker Hannifin 2.8%▼ −1.4%
  8. Amazon 2.7%▲ +37.1%
  9. Roivant Sciences Ltd 2.6%new
  10. Visa Inc. 2.5%▲ +50.6%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q4 2021

Positions Q4 2021 per 13F filing, 105 of 105
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 2.7% 278,199 927.6M USD +37.1% increased Q2 2015 27 quarters
MSFT Microsoft 2.9% 2,932,762 986.3M USD −19.5% reduced Q2 2016 23 quarters
V Visa Inc. 2.5% 3,971,579 860.7M USD +50.6% increased Q3 2016 22 quarters
Catalent Inc 0.4% 1,139,354 145.9M USD −2.0% reduced Q1 2018 16 quarters
CNC Centene Corporation 2.1% 8,618,638 710.2M USD −12.8% reduced Q2 2018 15 quarters
BSX Boston Scientific 2.3% 18,961,501 805.5M USD +176.1% increased Q3 2018 14 quarters
Adaptive Biotechnologies Cor 2.4% 29,993,708 841.6M USD unchanged Q2 2019 11 quarters
Bridgebio Pharma Inc 1.3% 26,620,991 444.0M USD unchanged Q2 2019 11 quarters
Avantor Inc 1.1% 8,787,342 370.3M USD +23.4% increased Q2 2019 11 quarters
AIZ Assurant 0.8% 1,723,771 268.7M USD −5.2% reduced Q2 2019 11 quarters
FTV Fortive 1.9% 8,484,942 647.3M USD −21.5% reduced Q3 2019 10 quarters
Guardant Health Inc 1.5% 5,074,389 507.5M USD +3.7% increased Q3 2019 10 quarters
Molina Healthcare Inc 0.4% 447,686 142.4M USD −52.1% reduced Q3 2019 10 quarters
TMUS T-Mobile US 4.4% 13,148,287 1.5B USD +28.6% increased Q1 2020 8 quarters
CB Chubb Limited 2.1% 3,691,765 713.7M USD +21.4% increased Q1 2020 8 quarters
PH Parker Hannifin 2.8% 3,056,921 972.5M USD −1.4% reduced Q2 2020 7 quarters
Api Group Corp 2.5% 33,333,333 859.0M USD unchanged Q2 2020 7 quarters
Royalty Pharma PLC 1.2% 10,315,378 411.1M USD +149.1% increased Q2 2020 7 quarters
Zentalis Pharmaceuticals Inc 0.5% 2,118,284 178.1M USD unchanged Q2 2020 7 quarters
TMO Thermo Fisher Scientific 0.4% 211,058 140.8M USD +15.8% increased Q2 2020 7 quarters
Pvh Corporation 0.2% 768,809 82.0M USD −33.8% reduced Q2 2020 7 quarters
ZBH Zimmer Biomet 0.9% 2,496,245 317.1M USD −26.8% reduced Q3 2020 6 quarters
Laboratory Corp Amer HLDGS 0.8% 850,147 267.1M USD +7.4% increased Q3 2020 6 quarters
Inhibrx Inc 0.7% 5,305,866 231.7M USD unchanged Q3 2020 6 quarters
Fleetcor Technologies Inc 0.6% 983,391 220.1M USD −60.2% reduced Q3 2020 6 quarters
PODD Insulet Corporation 0.5% 678,194 180.4M USD −33.1% reduced Q3 2020 6 quarters
BMY Bristol Myers Squibb 0.3% 1,815,619 113.2M USD −74.1% reduced Q3 2020 6 quarters
Karuna Therapeutics Inc 0.3% 863,664 113.1M USD −0.6% reduced Q3 2020 6 quarters
Pmv Pharmaceuticals Inc 0.1% 1,790,284 41.4M USD unchanged Q3 2020 6 quarters
GE GE Aerospace 4.9% 18,041,156 1.7B USD +6.6% increased Q4 2020 5 quarters
META Meta Platforms 1.8% 1,886,516 634.5M USD +10.6% increased Q4 2020 5 quarters
Match Group Inc New 0.7% 1,899,574 251.2M USD +39.2% increased Q4 2020 5 quarters
PANW Palo Alto Networks 0.6% 395,157 220.0M USD −69.0% reduced Q4 2020 5 quarters
MRSH Marsh McLennan 0.6% 1,261,570 219.3M USD +9.1% increased Q4 2020 5 quarters
NOW ServiceNow 0.4% 224,261 145.6M USD −59.9% reduced Q4 2020 5 quarters
Acadia Healthcare Company In 0.4% 2,090,576 126.9M USD −0.6% reduced Q4 2020 5 quarters
4D Molecular Therapeutics In 0.3% 3,937,914 86.4M USD unchanged Q4 2020 5 quarters
Kinnate Biopharma Inc < 0.1% 1,820,462 32.3M USD unchanged Q4 2020 5 quarters
Coupa Software Inc 1.9% 4,168,030 658.8M USD +6.4% increased Q1 2021 4 quarters
AMP Ameriprise Financial 1.3% 1,453,796 438.6M USD +3.8% increased Q1 2021 4 quarters
DE Deere & Company 0.9% 933,418 320.1M USD +29.9% increased Q1 2021 4 quarters
Tenet Healthcare Corp 0.8% 3,211,241 262.3M USD −4.3% reduced Q1 2021 4 quarters
Lithia Mtrs Inc 0.7% 791,084 234.9M USD −1.5% reduced Q1 2021 4 quarters
Zai Lab Ltd 0.6% 3,018,958 189.7M USD +2.9% increased Q1 2021 4 quarters
CRL Charles River Laboratories 0.4% 390,129 147.0M USD +119.9% increased Q1 2021 4 quarters
RUN Sunrun 0.4% 3,823,259 131.1M USD −56.6% reduced Q1 2021 4 quarters
Edgewise Therapeutics Inc 0.1% 2,727,249 41.7M USD unchanged Q1 2021 4 quarters
Pharvaris N V 0.1% 2,455,536 38.8M USD +2.7% increased Q1 2021 4 quarters
Orion Acquisition Corp 0.1% 3,669,272 36.1M USD −0.1% reduced Q1 2021 4 quarters
Gracell Biotechnologies Inc < 0.1% 491,647 3.0M USD −63.8% reduced Q1 2021 4 quarters
HUM Humana 3.6% 2,663,368 1.2B USD −11.4% reduced Q2 2021 3 quarters
Brookfield Asset Mgmt Inc 3.1% 17,603,102 1.1B USD +3.6% increased Q2 2021 3 quarters
Figs Inc 1.2% 14,742,689 406.3M USD unchanged Q2 2021 3 quarters
BKNG Booking Holdings 0.9% 128,278 307.8M USD −4.6% reduced Q2 2021 3 quarters
JD JD.com (ADR) 0.8% 3,765,921 263.9M USD −48.4% reduced Q2 2021 3 quarters
Intellia Therapeutics Inc 0.5% 1,579,536 186.8M USD +23.4% increased Q2 2021 3 quarters
Zoominfo Technologies Inc 0.5% 2,706,305 173.7M USD −29.9% reduced Q2 2021 3 quarters
Peloton Interactive Inc 0.4% 3,951,576 141.3M USD −39.1% reduced Q2 2021 3 quarters
Adapthealth Corp 0.3% 3,949,783 96.6M USD −3.0% reduced Q2 2021 3 quarters
Talaris Therapeutics Inc 0.1% 3,289,617 50.3M USD unchanged Q2 2021 3 quarters
Day One Biopharmaceuticals I < 0.1% 1,157,424 19.5M USD −4.5% reduced Q2 2021 3 quarters
Ginkgo Bioworks Holdings Inc 8.2% 339,055,144 2.8B USD unchanged Q3 2021 2 quarters
CMCSA Comcast 2.1% 14,213,091 715.3M USD +39.7% increased Q3 2021 2 quarters
UBER Uber 1.3% 10,584,794 443.8M USD +65.6% increased Q3 2021 2 quarters
Hdfc Bank Ltd 0.9% 4,852,938 315.8M USD +189.0% increased Q3 2021 2 quarters
Mcdonalds Corp 0.7% 958,248 256.9M USD −68.0% reduced Q3 2021 2 quarters
WTW Willis Towers Watson 0.7% 962,328 228.5M USD −17.0% reduced Q3 2021 2 quarters
Farfetch Ltd 0.6% 5,946,096 198.8M USD −48.5% reduced Q3 2021 2 quarters
TSLA Tesla, Inc. 0.5% 173,672 183.5M USD −54.8% reduced Q3 2021 2 quarters
Procept Biorobotics Corp 0.4% 4,907,892 122.7M USD unchanged Q3 2021 2 quarters
Olaplex HLDGS Inc 0.1% 1,613,189 47.0M USD −46.6% reduced Q3 2021 2 quarters
Icosavax Inc 0.1% 1,796,800 41.1M USD −3.0% reduced Q3 2021 2 quarters
Rallybio Corp 0.1% 4,194,777 40.0M USD unchanged Q3 2021 2 quarters
Vtex < 0.1% 3,023,280 32.4M USD −0.6% reduced Q3 2021 2 quarters
Nuvalent Inc < 0.1% 1,647,671 31.4M USD unchanged Q3 2021 2 quarters
Celldex Therapeutics Inc New < 0.1% 757,881 29.3M USD −0.6% reduced Q3 2021 2 quarters
On Hldg AG < 0.1% 300,000 11.3M USD unchanged Q3 2021 2 quarters
Meli Kaszek Pioneer Corp < 0.1% 880,185 10.2M USD −12.0% reduced Q3 2021 2 quarters
SEMA4 Holdings Corp < 0.1% 1,226,307 5.5M USD −59.1% reduced Q3 2021 2 quarters
Roivant Sciences Ltd 2.6% 88,238,700 889.4M USD new Q4 2021 1 quarter
TWLO Twilio 2.3% 2,980,398 784.9M USD new Q4 2021 1 quarter
WDAY Workday, Inc. 1.4% 1,751,589 478.5M USD new Q4 2021 1 quarter
AON Aon plc 1.3% 1,510,517 454.0M USD new Q4 2021 1 quarter
RIVN Rivian Automotive 1.0% 3,204,389 332.3M USD new Q4 2021 1 quarter
Global E Online Ltd 0.9% 5,038,891 319.4M USD new Q4 2021 1 quarter
Biomarin Pharmaceutical Inc 0.7% 2,869,947 253.6M USD new Q4 2021 1 quarter
TTWO Take-Two Interactive 0.6% 1,203,961 214.0M USD new Q4 2021 1 quarter
FDX FedEx 0.5% 655,242 169.5M USD new Q4 2021 1 quarter
AIG American International Group 0.5% 2,903,295 165.1M USD new Q4 2021 1 quarter
LI Li Auto 0.4% 4,485,985 144.0M USD new Q4 2021 1 quarter
SE Sea Limited (ADR) 0.3% 440,129 98.5M USD new Q4 2021 1 quarter
WDC Western Digital 0.2% 1,311,029 85.5M USD new Q4 2021 1 quarter
Zillow Group Inc 0.2% 1,258,215 80.3M USD new Q4 2021 1 quarter
IFF International Flavors & Fragrances 0.2% 510,985 77.0M USD new Q4 2021 1 quarter
XYZ Block, Inc. 0.2% 454,947 73.5M USD new Q4 2021 1 quarter
XPEV XPeng 0.2% 1,456,496 73.3M USD new Q4 2021 1 quarter
Amedisys Inc 0.2% 391,131 63.3M USD new Q4 2021 1 quarter
KKR KKR & Co. 0.2% 806,081 60.1M USD new Q4 2021 1 quarter
BEKE KE Holdings 0.2% 2,920,256 58.8M USD new Q4 2021 1 quarter
PHM PulteGroup 0.2% 913,668 52.2M USD new Q4 2021 1 quarter
Biohaven Pharmactl Hldg Co L 0.1% 348,783 48.1M USD new Q4 2021 1 quarter
APO Apollo Global Management 0.1% 538,212 39.0M USD new Q4 2021 1 quarter
Abiomed Inc < 0.1% 82,572 29.7M USD new Q4 2021 1 quarter
Tdcx Inc < 0.1% 1,014,497 19.4M USD new Q4 2021 1 quarter
Lianbio < 0.1% 1,500,000 9.2M USD new Q4 2021 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 2 positions in convertible bonds and bonds worth 217.0M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 120.0M USD 122.0M USD
  • Coupa Software Inc principal 100.0M USD 95.0M USD

Breakdown by sector

  • Industrials 12.7%
  • Health Care 10.6%
  • Financials 10.2%
  • Communication Services 9.0%
  • Technology 7.8%
  • Consumer Discretionary 5.2%
  • Materials 0.2%
  • not in our coverage 44.3%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close